Jefferies Upgrades Centessa Pharmaceuticals to Buy, Raises Price Target to $11
Jefferies Upgrades Centessa Pharmaceuticals to Buy, Raises Price Target to $11
傑富瑞上調Centessa Pharmicals收購，將目標股價提高至11美元
Jefferies analyst Kelly Shi upgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Hold to Buy and raises the price target from $4 to $11.
傑富瑞分析師凱利·施將Centessa Pharmicals（納斯達克股票代碼：CNTA）從持有上調至買入，並將目標股價從4美元上調至11美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。